+24.1%
NOW vs GSK
-10.9%
+35.0%
-34.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.0% | -1.9% | -1.0% | -3.5% |
| 7D | -2.4% | -1.8% | -0.6% | -2.9% |
| 30D | +20.5% | -2.2% | +22.7% | +19.8% |
| 3M | +18.3% | -1.8% | +20.2% | +18.5% |
| 6M | +24.1% | -10.6% | +34.7% | +16.9% |
| All | +24.1% | -10.9% | +35.0% | +16.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling